Evercore ISI reiterates Texas Instruments stock rating on AI potential By Investing.com

Evercore ISI reiterated an Outperform rating on Texas Instruments with a $270 price target, implying upside from the recent $229.82 share price and citing positive first-quarter setup, improving ASPs, and stronger gross margin potential. The firm also highlighted TXN as an emerging AI-power play, with data center revenue now about 10% of sales, while noting elevated valuation and crowded long positioning as offsetting risks. Separately, Texas Instruments announced a $1.42 quarterly dividend payable May 19, 2026, and other brokers recently raised ratings or price targets.

Analysis

TXN is functioning less like a cyclical analog proxy and more like a “quality-duration” compounder: investors are paying up for a visible 2026/27 AI-power optionality stream while still underestimating how much of the near-term rerating is already embedded. The second-order benefit is that TXN’s high internal manufacturing intensity becomes a strategic moat in a world of supply-chain nationalism and tighter export controls; that lowers execution risk versus fab-light peers, but it also means the market may be over-assigning margin permanence to a recovery that is still volume-dependent.

The key setup into earnings is not whether demand is improving, but whether gross margin slope can continue to inflect faster than consensus models. If pricing and mix are both turning, the stock can keep squeezing higher because under-owned investors are forced to chase, but any hint that ASP gains are transitory will matter more than revenue beats. The elevated multiple leaves little room for a “good but not great” print; this is a stock where guide quality, not EPS, should dominate the next 2-6 weeks.

Contrarian risk: the market is likely treating data-center exposure as an AI-call option with too much duration, when in reality it may behave more like a slow-burn industrial upgrade cycle. The cleanest disconfirmation is not a demand collapse, but a normalization in lead times and pricing that reveals this is an above-trend analog upcycle rather than a structural re-rating. In that case, the next leg is not necessarily down hard, but sideways to lower as valuation compresses while estimates grind up.

Key Decisions for Investors

• Trim long TXN into earnings strength; use the event to de-risk 20-30% of position if shares remain near highs, since the setup is already crowded and valuation leaves limited upside on an in-line print.
• If maintaining exposure, express it via call spreads rather than stock: buy TXN 3-6 month call spreads to capture a further rerate while defining downside if gross margin guidance disappoints.
• Pair trade: long TXN / short a higher-beta analog peer basket into the print only if you believe the recovery is broadening; otherwise reverse it post-earnings if TXN beats but guide is merely solid, not accelerating.
• For a cleaner contrarian entry, wait for a post-earnings pullback of 5-8% and buy TXN only if management confirms pricing discipline and AI-power revenue ramps in 2026; that offers better risk/reward than chasing pre-print.
• Monitor for evidence that margin expansion is mix-driven versus pricing-driven; if ASP commentary weakens, fade the stock because the multiple is being supported by a margin narrative, not just cyclical recovery.